The failure of an experimental drug that targets clumps of protein inside the brains of Alzheimer's patients called into question one of the leading theories about the cause of the dementia.
Read more: http://www.npr.org/sections/health-shots/2016/12/29/506592761/where-does-alzheimer-s-treatment-go-from-here?source=Snapzu
No comments:
Post a Comment